Current Report Filing (8-k)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 29 , 201 9

Acacia Diversified Holdings, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Texas	1-14088	75-2095676
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

13575 58th Street North - #138 Clearwater, FL 33760

(Address of Principal Executive Offices)

(727) 678-4420

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None	None	None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Forward-Looking Statements

Statements in this Current Report on Form 8-K may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to the Company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Acacia, MariJ Pharmaceuticals, Inc. or Eufloria Medical of Tennessee, Inc. or websites does not constitute a part of this Current Report.

Section 8 – Other Events

Item 8.01 Other Events

Acacia Diversified Holdings, Inc. (“Acacia” or the “Company”) (OTCQB symbol: ACCA), an emerging medicinal hemp company, through its wholly owned subsidiaries, MariJ Pharmaceuticals, Inc. (MariJ), MEDAHUB Companies, Inc. (MEDAHUB) and Eufloria Medical of Tennessee, Inc. (Eufloria) is focused on the growing and distribution of new and proprietary medicinal hemp products for patients, USDA certified organic mobile processing and handling solutions for its customers, and technology solutions for the expanding physician market. The Company is pleased to announce that it has completed phase one of the construction work for 16,000 Sq./ft of the indoor medicinal hemp growing space at the Tennessee farm. Phase two is underway with 480v/277v three phase power being brought to the building, installation of all HVAC dehumidifiers and lighting, with a stationary extraction facility capable of processing hundreds of pounds of hemp per day.

We expect that we will have an indoor and outdoor harvest this season at the farm location in this evolving medicinal hemp market. The Company has deployed its software technology which is now tracking each plant all the way through to end product, from soil to oil! Eufloria, (www.eufloriamedical.com) will be growing from clones, processing and manufacturing a product line that is whole plant CO2, extracted by its sister company “MariJ” (www.marijinc.com) which has just completed processing and manufacturing a 2,000 lbs. contract and added a 500 additional pound addendum for processing of USDA certified organic hemp for its customers in Nashville. This phase completion continues to provide increased revenue from 4Q 2018, through 2Q 2019. We anticipate that we will continue to produce high quality products at a pharmaceutical level and we will stay dedicated to working on GMP’s and ISO certification along with FDA compliances at our farm location and through the Company mobile unit.

About the Company:

Acacia Diversified Holdings has a wholly-owned subsidiary for growing hemp called Eufloria and it uses its processing and manufacturing company, MariJ to create consumer products for distribution under the Eufloria brand. Dahlia’s Botanicals is another part of the Acacia portfolio, with a portion of sales from its USDA Certified Organic Hemp product going to the Cannamoms organization.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.